HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Drug eruption due to bosentan in a patient with systemic sclerosis.

Abstract
We present the case of a 60-year-old female patient with systemic sclerosis complicated by pulmonary hypertension. Ten days after the initiation of treatment with bosentan, high fever and skin eruptions were noted. In the previous reports, the frequency of drug-induced skin eruptions has not been well documented. Since the use of bosentan is expected to increase, we should be aware of the previously unknown adverse effects as well as skin eruptions.
AuthorsYayoi Nagai, Masayoshi Yamanaka, Shigeru Nishimura, Akihiko Nakano, Akira Hasegawa, Osamu Ishikawa
JournalModern rheumatology (Mod Rheumatol) Vol. 16 Issue 3 Pg. 188-90 ( 2006) ISSN: 1439-7595 [Print] England
PMID16767560 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Sulfonamides
  • Prednisolone
  • Bosentan
Topics
  • Anti-Inflammatory Agents (administration & dosage)
  • Antihypertensive Agents (adverse effects)
  • Bosentan
  • Drug Eruptions
  • Endothelin Receptor Antagonists
  • Eosinophilia (etiology)
  • Female
  • Humans
  • Hypertension, Pulmonary (complications, drug therapy)
  • Middle Aged
  • Prednisolone (administration & dosage)
  • Scleroderma, Systemic (complications)
  • Sulfonamides (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: